Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 306-5251, Iss. 4, 2015-10 ,pp. : 670-677

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects

By Robertson Sarah M.   Davey Richard T.   Voell Jocelyn   Formentini Elizabeth   Alfaro Raul M.   Penzak Scott R.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 591-599

Informa Healthcare

Access to resources Recommend Favorite

Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

By He Yan-Ling   Sabo Ron   Riviere Gilles-Jacques   Sunkara Gangadhar   Leon Selene   Ligueros-Saylan Monica   Rosenberg Mitchell   Dole William P.   Howard Dan  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1131-1138

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairment

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 5, 2015-05 ,pp. : 525-533

John Wiley & Sons Inc

Access to resources Recommend Favorite

Surface-stabilized lopinavir nanoparticles enhance oral bioavailability without coadministration of ritonavir

By Jain Sanyog   Sharma Jagadish M   Jain Amit K   Mahajan Rahul R  

Nanomedicine, Vol. 8, Iss. 10, 2013-10 ,pp. : 1639-1655

Future Medicine

Access to resources Recommend Favorite